Approval · Notice of Compliance 12023 · 2011
TEVA-ACYCLOVIR: Notice of Compliance 12023
Issued January 24, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12023
- Date
- January 24, 2011
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-ACYCLOVIR | 02285959 | Marketed |
| TEVA-ACYCLOVIR | 02285967 | Marketed |
| TEVA-ACYCLOVIR | 02285975 | Marketed |